OncologyTube Professional - Patients Click Here
236,859 video views
Loading........
Description: Tian Zhang, MD, Assistant Professor of Medicine, Duke Cancer Institute, Discusses Discussing PEDIGREE Study. At The 2019 Genitourinary Cancers Symposium In San Francisco, CA On Feb 14, 2019.

http:/...
01:32
Tian Zhang, MD, Assistant Professor of Medicine, Duke Cancer Institute, Discusses Discussing PEDIGREE Study. At The 2019 Genitourinary Cancers Symposium In San Francisco, CA On Feb 14, 2019. http://obron......
by:obr | 298 views
02:57
Evan Yu, MD, Professor, Department of Medicine, Division of Oncology, University of Washington, Fred Hutchinson Cancer Research Institute, Discusses Results From KEYNOTE 365 In mCRPC. At The 2019 Genitourinary Cancers Symposium In San Francisco, CA On Feb 14, 2019. http://obron...
by:obr | 472 views
01:39
Evan Yu, MD, Professor, Department of Medicine, Division of Oncology, University of Washington, Fred Hutchinson Cancer Research Institute, Discusses When Sipuleucel-T Should Be Used In Treatment Of mCRPC. At The 2019 Genitourinary Cancers Symposium In San Francisco, CA On Feb 14, 2019. http://obron...
by:obr | 278 views
01:28
Evan Yu, MD, Professor, Department of Medicine, Division of Oncology, University of Washington, Fred Hutchinson Cancer Research Institute, Discusses Combining Checkpoint Inhibitors In Metastatic Castration-Resi​stant Prostate Cancer. At The 2019 Genitourinary Cancers Symposium In San Francisco, CA On...
by:obr | 290 views
02:17
Evan Yu, MD, Professor, Department of Medicine, Division of Oncology, University of Washington, Fred Hutchinson Cancer Research Institute, Discusses Combination Pembrolizumab And Olaparib In mCRPC. At The 2019 Genitourinary Cancers Symposium In San Francisco, CA On Feb 14, 2019. http://obron...
by:obr | 295 views
00:57
Sumit K. Subudhi, MD, PhD, Assistant Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Discusses When Sipuleucel-T Should Be Used In Treatment Of mCRPC. At The 2019 Genitourinary Cancers Symposium In San Francisco, CA On Feb 14, 2019. http://obron...
by:obr | 140 views
00:41
Sumit K. Subudhi, MD, PhD, Assistant Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Discusses Combining Checkpoint Inhibitors In mCRPC. At The 2019 Genitourinary Cancers Symposium In San Francisco, CA On Feb 14, 2019. http://obron...
by:obr | 30 views
00:44
Sumit K. Subudhi, MD, PhD, Assistant Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Discusses The Outcomes Of The KEYNOTE 365 Study. At The 2019 Genitourinary Cancers Symposium In San Francisco, CA On Feb 14, 2019. http://obron...
by:obr | 29 views
01:25
Bridget F. Koontz, MD, Associate Professor of Radiation Oncology, Duke University School of Medicine, Discusses Moderate Hypofractionati​on & Ultra-Hypofractionati​on In Prostate Cancer. At The 2019 Genitourinary Cancers Symposium In San Francisco, CA On Feb 14, 2019. http://obron...
by:obr | 14 views
01:59
Bridget F. Koontz, MD, Associate Professor of Radiation Oncology, Duke University School of Medicine, Discusses The Evolving Landscape Of Prostate Cancer. At The 2019 Genitourinary Cancers Symposium In San Francisco, CA On Feb 14, 2019. http://obron...
by:obr | 88 views

About obr
Description: OBR is the most comprehensive digital platform for oncology focused news and information: We aggregate, customize and prioritize daily oncology news and publications (OBR Daily for industry and providers, RSS newsfeeds) We research, develop and publish original content (OBR green) We create and produce customized training programs for pharmaceutical professionals (Oncology Business Dynamics) We conduct, interpret, analyze and produce original research (On-Telligence) We publish informational resources and editorial perspective to our websites (OBR Radar, Pipeline Online, Blog, Twitter, OBR Finance, News Pulse, KOL Commentary, and others)

Links
Channel Url:

Website:


Social Links: